Vaxtex Cotfab Ltd
Textiles | Small Cap
Vaxtex Cotfab Ltd, operating in the Textiles & Apparel sector, shows a mixed financial performance. The company demonstrates some strengths in solvency and asset growth, but faces significant challenges in profitability, efficiency, and coverage. While the company has managed to reduce its debt levels, its ability to generate profit from its operations is severely hampered. Revenue and net income have declined, impacting overall financial health. The company's efficiency in managing inventory and receivables is also a concern. The high asset growth rate is a positive sign, but it needs to translate into improved financial performance to ensure long-term sustainability. Overall, there are both positive and negative aspects to the company's financial situation, suggesting a need for strategic improvements in key areas.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.00
- Financial Ratio3.60
- Profitability Ratio2.00
- Efficiency Ratio2.50
- Coverage Ratio2.00
- Solvency Ratio10.00
- Liquidity Ratio0.00
- Peer Assessment
- Management AssessmentWeak
- Risk AssessmentWeak
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Vaxtex Cotfab Ltd, operating in the Textiles & Apparel sector, shows a mixed financial performance. The company demonstrates some strengths in solvency and asset growth, but faces significant challenges in profitability, efficiency, and coverage. While the company has managed to reduce its debt levels, its ability to generate profit from its operations is severely hampered. Revenue and net income have declined, impacting overall financial health. The company's efficiency in managing inventory and receivables is also a concern. The high asset growth rate is a positive sign, but it needs to translate into improved financial performance to ensure long-term sustainability. Overall, there are both positive and negative aspects to the company's financial situation, suggesting a need for strategic improvements in key areas.
Overall Valuation Score
P/E RATIO (TTM)
23.78
Industry Median
25.37
Small Cap Median
25.37
P/E RATIO
42.80
P/B RATIO
2.28
Industry Median
1.58
Small Cap Median
1.58
P/S RATIO
N/A
Industry Median
1.09
Small Cap Median
1.09
Others
PEG RATIO
0.74
EV/EBITDA RATIO
62.50
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹2.14 as on Feb 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company's growth ratios present a conflicting picture. While asset growth and operating profit growth are strong, revenue and net income growth are poor. The company is expanding its asset base and improving operating profits, but revenue and net income are not keeping pace. This discrepancy raises concerns about the sustainability of growth. It is important to focus on strategies to translate asset growth into improved revenue and profitability.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Growth Rate | 5.11 | 109.03 | -104.98 | 4166.67 | -92.19 |
| Earnings Per Share (EPS) Growth | 0 | 900 | -40 | -900 | -110.42 |
| Asset Growth Rate | N/A | 10.6 | 189.62 | -29.66 | -0.82 |
| Net Income Growth Rate | N/A | N/A | N/A | N/A | N/A |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios reveal several challenges. Negative adjusted and cash earnings per share, along with a low book value per share, indicate poor profitability and asset utilization. While capital expenditures are well-managed, the overall financial performance is weak. The company must focus on improving earnings and asset efficiency to enhance its financial health.
| Financial Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | N/A | N/A | N/A | N/A | N/A |
| Cash Earnings Per Share (Cash EPS) | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 1.47 | 1.03 | 1.86 | 1.02 | 1 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 0 | 0 | 0 | 0 | 0 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability ratios reflect significant challenges. Negative gross profit margin, ROCE, ROE, ROA, operating margin, and net margin all indicate poor performance. The company is struggling to generate profit from its operations and assets. This raises concerns about financial sustainability. The company needs to implement strategies to improve profitability across all key metrics.
| Profitability Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A |
| Return on Capital Employed (ROCE) | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (ROE) | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (ROA) | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency ratios reveal significant challenges. Low inventory and receivables turnover, coupled with prolonged receivable days and days sales in inventory, suggests inefficient asset management. While the company may be holding inventory for longer periods, it could be a sign of slow sales or obsolete stock. Similarly, extended receivable days indicate difficulties in collecting payments, affecting cash flow. The company needs to streamline its operations to improve efficiency and reduce working capital requirements.
| Efficiency Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover Ratio | N/A | N/A | N/A | N/A | N/A |
| Receivables Turnover Ratio | N/A | N/A | N/A | N/A | N/A |
| Days Sales in Inventory Ratio | N/A | N/A | N/A | N/A | N/A |
| Receivable Days | N/A | N/A | N/A | N/A | N/A |
| Capital Turnover Ratio | 0 | 0 | 0 | 0 | 0 |
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
The company's coverage ratios indicate significant weaknesses. A negative interest coverage ratio raises concerns about the ability to meet interest obligations. This situation suggests potential financial distress and increases the risk of default. The company needs to improve its earnings or restructure its debt to address these coverage issues.
| Coverage Ratios | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Interest Coverage Ratio | 1.18 | 1.24 | 2.86 | 2.84 | -125.14 | 4.82 |
| Equity Dividend Coverage Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position presents a mixed view. While debt ratios indicate a relatively low debt burden, the negative interest coverage ratio raises concerns about the ability to meet interest obligations. Lower debt can provide financial flexibility, but the inability to cover interest payments suggests potential financial distress. It is important to consider the long-term implications of these conflicting signals on the company's overall financial stability.
| Solvency Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to Equity Ratio | 0 | 0 | 0 | 0 | 0 |
| Equity Ratio | 1 | 1 | 1 | 1 | 1 |
| Debt To Asset Ratio | 0 | 0 | 0 | 0 | 0 |
Debt Ratio
Debt to Equity Ratio
Interest Coverage Ratio
The company's liquidity position cannot be reliably assessed due to missing data. A comprehensive analysis of current, quick, and cash ratios, alongside operating cash flow, is essential to determine the company's short-term financial health. Without this data, it's impossible to ascertain whether the company can meet its immediate obligations or manage unforeseen financial challenges.
| Liquidity Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Cash Ratio | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow Ratio | N/A | N/A | N/A | N/A | N/A |
Current Ratio
Quick Ratio
Cash Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Vaxtex Cotfab Ltd | 3.69 | 42.80 | Neutral | -0.50 | 0.05 | 0.88 |
The management effectiveness of Vaxtex Cotfab Ltd is weak due to inconsistent financial performance, declining sales and profit growth, negative operating profit margins, and poor returns on capital employed and equity. The significant decrease in promoter holding raises concerns about long-term commitment. These factors suggest challenges in strategic direction and operational efficiency.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| CONS | TTM Sales Growth | -96% | Indicates a significant downturn in sales |
| ROCE | -20.71% | Shows ineffective capital utilization | |
| Promoter Holding (Mar 2024) | 18.10% | Significant decrease raises concerns about commitment | |
| TTM Profit Growth | -1010% | Indicates significant losses |
Financial Performance & Growth
Vaxtex Cotfab Ltd. exhibits poor financial performance and growth. The compounded sales growth and profit growth have been inconsistent. The recent TTM sales growth is at -96%, and TTM profit growth is at -1010%, indicating a significant downturn. Quarterly sales have also declined substantially, with recent quarters showing 0.00 sales. The operating profit margin (OPM) is negative, with a TTM of -588.10%. This indicates operational inefficiencies and an inability to generate profits from its core business activities.
| Metric | 2016-2018 | 2019-2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Sales Growth (%) | 307.5% | 12.5% | 137% | 22% | -78% | N/A |
Capital Efficiency & Returns
Capital efficiency and returns for Vaxtex Cotfab Ltd. are poor. The ROCE is -20.71%, and ROE is -41.80%, indicating the company is not effectively utilizing capital or generating returns for shareholders. The negative ROCE indicates that the company is destroying value rather than creating it. This suggests significant issues in capital allocation and operational management.
| Metric | 2016-2018 | 2019-2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| ROCE (%) | 2.92% | 9.81% | 16.71% | 2.02% | -20.71% |
Financial Health & Prudence
The financial health and prudence of Vaxtex Cotfab Ltd. are weak. While the interest coverage ratio cannot be reliably calculated due to negative or near-zero operating profits, the increasing borrowings and fluctuating debt/equity ratio point to potential financial strain. The borrowings have increased from ₹5.20 Cr in Mar 2023 to ₹11.52 Cr in Mar 2024. The company's dividend payout is consistently at 0.00%, which could be a concern for investors seeking regular income.
| Metric | 2016-2018 | 2019-2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Average Borrowings (Cr) | 0.17 | 8.74 | 7.45 | 5.20 | 11.52 |
Shareholding & Ownership Structure
The shareholding and ownership structure of Vaxtex Cotfab Ltd. present significant concerns. There has been a substantial decrease in promoter holding from 73.66% in Mar 2022 to 18.10% in Mar 2024. This large reduction may indicate a lack of confidence by the promoters in the company's future prospects. The absence of significant institutional holding (FII/DII) further underscores potential issues with investor confidence and long-term stability.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Promoter Holding (%) | 73.50% | 73.61% | 73.66% | 26.14% | 18.10% | 18.10% |
The overall risk assessment for Vaxtex Cotfab Ltd. is red due to financial instability and operational challenges. The company exhibits declining profitability, high volatility in segment performance, and concerning trends in working capital management. The drastic reduction in promoter holding raises governance and confidence concerns, indicating a high-risk profile.
Segment performance volatility
The quarterly results show high volatility in sales and profit growth. The YOY Sales Growth % fluctuates significantly, including periods of substantial decline such as -100%. Similarly, YOY Profit Growth % is highly variable, with large negative swings such as -4833%. This variability indicates operational instability and difficulty in maintaining consistent financial performance.
Accounting quality red flags
Material Cost % has spiked to 385.10% in Dec 2023, which is unusual. The Sales growth is also declining to -102% in Mar 2024 which shows weakness in accounting quality.
Working Capital Management
The company's working capital management shows inefficiency. Debtor Days have increased significantly to 345.02 in Mar 2024, indicating difficulties in collecting receivables. The Cash Conversion Cycle is also highly variable, suggesting inconsistent management of working capital. Overall, these factors indicate poor liquidity and operational inefficiencies.
Contingent liability evaluation
Other Liabilities have increased significantly from 6.18 Cr in Mar 2022 to 18.55 Cr in Mar 2024. This suggests potential hidden obligations or financial strain that could impact the company's future financial health.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe